Ambrx Biopharma - Stock Split History | AMAM

Stock split history for Ambrx Biopharma since 2022. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Ambrx Biopharma Annual Stock Splits
Ambrx Biopharma Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.007B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $169.944B 10.37
GSK (GSK) United Kingdom $75.002B 9.40
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.102B 18.95
Ginkgo Bioworks Holdings (DNA) United States $3.395B 0.00
Myovant Sciences (MYOV) United Kingdom $2.599B 0.00
Arcus Biosciences (RCUS) United States $2.277B 34.17
Biohaven (BHVN) United States $1.119B 0.00
Emergent Biosolutions (EBS) United States $0.618B 4.85
Zymeworks (ZYME) Canada $0.466B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.220B 0.00
Enzo Biochem (ENZ) United States $0.090B 0.00
SQZ Biotechnologies (SQZ) United States $0.036B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00